Idenix Pharmaceuticals, Inc. leads Friday small-cap pre-market volume
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) said the FDA has essentially rejected its hepatitis C drug. Idenix is “not optimistic” about the drug’s future prospects, CEO Jean-Pierre Sommadossi said.
The following are the most actively traded companies in Friday pre-market trading among those with market capitalizations under $500 million:
| Price at | % | ||||||
| 9:17 et | Change | Change | Volume | Year High | Year Low | ||
| IDIX | IDENIX PHARMACEUTICALS INC | 4.28 | -1.51 | -26.1% | 252.1k | 10.83 | 5.59 |
| HOKU | HOKU SCIENTIFIC INC | 14.20 | +0.50 | +3.6% | 234.3k | 14.39 | 2.12 |
| LOCM | LOCAL COM CORP | 8.72 | +0.11 | +1.3% | 101.9k | 13.74 | 3.05 |
| SBEI | SBE INC | 6.25 | -0.39 | -5.8% | 30.8k | 8.30 | 1.25 |
| ARIA | ARIAD PHARMACEUTICALS INC | 5.82 | +0.05 | +0.9% | 23.7k | 6.40 | 3.27 |
| NEXT | NEXTEST SYS CORP | 12.00 | -1.30 | -9.8% | 13.6k | 16.40 | 9.38 |
| SIFY | SIFY LTD | 10.34 | +0.09 | +0.9% | 12.5k | 11.93 | 7.31 |
| VIMC | VIMICRO INTL CORP | 6.05 | -0.95 | -13.6% | 10.7k | 13.92 | 4.84 |
| JSDA | JONES SODA CO | 16.43 | +0.26 | +1.6% | 8.8k | 32.60 | 7.51 |
| VSCN | VISUAL SCIENCES INC | 18.60 | -0.40 | -2.1% | 5.0k | 19.30 | 9.60 |
About the Author
Reporter Will Atkinson is based in SmallCapInvestor.com's Washington, D.C. bureau.